Last reviewed · How we verify
Femarelle
At a glance
| Generic name | Femarelle |
|---|---|
| Sponsor | Hadassah Medical Organization |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Effect of DT56a (Femarelle) on the Coagulation System in the Treatment of Postmenopausal Women
- A Twelve Week Study to Investigate the Efficacy of Femarelle®, for the Treatment of Post Menopausal Vaginal Atrophy (NA)
- Natural Soybean-derived Femarelle ®for Patients With Non Alcoholic Fatty Liver Disease (PHASE4)
- A Double-Blind Study to Evaluate the Effect of Femarelle® on Menopausal on Vasomotor Symptoms (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |